{
    "Case ID": "022006",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent infringement dispute between brand-name and generic pharmaceutical manufacturers"
    ],
    "Legal_Issue": [
        "Whether Nu-Pharm's process is an obvious chemical equivalent of Abbott's patented process"
    ],
    "Governing_Law": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Procedural_Stage": [
        "Summary proceedings"
    ],
    "Evidence_Assessment": [
        "Expert affidavits and solubility data from the Merck Index were considered; court found solubility data supported Abbott's position"
    ],
    "Decision_Outcome": [
        "Nu-Pharm's process found to be an obvious chemical equivalent; application for Notice of Compliance denied"
    ],
    "Burden_of_Proof": [
        "On Abbott to demonstrate infringement of a valid patent"
    ],
    "Credibility_Factor": [
        "Experts disagreed on equivalence, but court credited Abbott's expert evidence and scientific data"
    ],
    "Legal_Rule": [
        "A generic manufacturer cannot market a drug if it infringes a valid patent; Claim 6 covers obvious chemical equivalents"
    ],
    "Standard_of_Review": [
        "Objective assessment of whether the alternative process is an obvious chemical equivalent"
    ],
    "Procedural_Issue": [
        "Use of summary proceedings under the NOC Regulations"
    ],
    "Grounds_for_Claim": [
        "Alleged infringement of Claim 6 of Abbott’s patent by use of water and room temperature in manufacturing process"
    ],
    "Outcome_on_Merits": [
        "Abbott succeeded on the merits; infringement established"
    ],
    "Decision_Maker": [
        "Court hearing the application under the NOC Regulations"
    ],
    "Judicial_Review_Outcome": [
        "Not applicable – this was the initial decision, not a review"
    ],
    "Review_Standard": [
        "Not applicable"
    ],
    "Procedural_Fairness_Assessment": [
        "Parties had opportunity to submit evidence; process conducted via summary proceedings with affidavit evidence"
    ],
    "Key_Evidence_Considered": [
        "Expert affidavits, solubility data from the Merck Index"
    ],
    "Legal_Framework": [
        "Regulatory framework governing generic drug approval and patent protection in Canada"
    ],
    "Applicant_Challenge": [
        "Abbott challenged Nu-Pharm's eligibility for a Notice of Compliance"
    ],
    "Court_Result": [
        "In favor of Abbott"
    ],
    "Legal_Rule_Source": [
        "Patented Medicines (Notice of Compliance) Regulations, Claim 6 of Abbott Patent"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Nu-Pharm argued their process using water and room temperature was not an obvious chemical equivalent"
    ],
    "Evidence_Type": [
        "Affidavit evidence, scientific literature (Merck Index)"
    ],
    "Remedy_Requested": [
        "Prevention of Nu-Pharm obtaining a Notice of Compliance"
    ],
    "Outcome": [
        "Nu-Pharm prohibited from receiving Notice of Compliance until patent expiration"
    ],
    "Decision_Authority": [
        "Federal Court (implied under NOC Regulations)"
    ],
    "Remedy_Sought": [
        "Interlocutory injunction or equivalent relief to block regulatory approval"
    ],
    "Resolution_Mechanism": [
        "Summary judicial proceeding under regulatory regime"
    ],
    "Legal_Provision": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Authority": [
        "Canadian Federal Court"
    ],
    "Claimant_Status": [
        "Abbott as patent holder"
    ],
    "Legal_Provision_Cited": [
        "Claim 6 of Abbott’s patent"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Infringement of valid patent through use of obvious chemical equivalent"
    ],
    "Applicable_Process": [
        "Notice of Compliance (NOC) proceedings under PM(NOC) Regulations"
    ],
    "Outcome_of_Review": [
        "Not applicable"
    ],
    "Pending_Relief_or_Application": [
        "Application to prevent grant of NOC to Nu-Pharm"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ]
}